Skip to main content

Table 1

From: Chromosomal aberrations in benign and malignant Bilharzia-associated bladder lesions analyzed by comparative genomic hybridization

   Histopathology   FISH CGH imbalances
Lab No Sex/Age Type Grade Stage Other   Losses Gains
Benign         
747–98 M/65 Ch. inflammation       
738–98 F/53 Ch. inflammation       
162–99 M/70 Ch. Inflammation Moderate dysplasia       
548–98 M/51 Granuloma    CBO    
352–99 F/55 Granuloma    CBO Xc 3, AR 1   
286–98 M/45 Granuloma with inflammatory polyp     9c 1, 17c 2 9p, 16p, 22q  
Malignant         
453–99 F/49 SCC G1 ? CBO topo 1   
2228–99 F/60 SCC G1   CBO 9c 1, 17c 3, Xc 3 1 cen-p31, 3p,9pter-q13 19p
229–99 M/70 SCC G2 T3 KCs Xc 2, 17c 2   
210–99 M/70 SCC G3 T3 KCs    
471–99 M/60 SCC G3 ? CBO+SM Xc 2, 17c 3   
217–98 F/51 SCC G3 T3 CBO   9p  
476–98 M/53 SCC G3 T3 CBO 9c 2, 17c 3 1p21-p22, 2q13-q21, 8p, 13q, 18q 19p
479–98 M/47 SCC G2–3   CBO   2q13-q21, 8p 19p
345–98 M/61 TCC G1 ? CBO+SM    
240–98 F/55 TCC G2 ?   Xc 1, 9c 2,17c 2   
746–98 F/60 TCC G2    Xc 2–3, 9c2–3, 17c 2–6(4)   
4540–98 M/62 TCC G2 ?     
5605–97 M/50 TCC G3 T3 SM Xc 2, AR 3–5 8p21-pter  
5653–98 F/50 TCC G3 T3   Xc 1–3, 9c 2, 17c 2 1 cen-p31 5p, 17q, 20q
  1. SCC, squamous cell carcinoma; TCC, transitional cell carcin oma; G1, well differentiated; G2, moderately differentiated; G3, poorly differ entiated; CBO, calcified bilharzial ova; I K:Cs, keratinzed cells; SM, squamous metapla